Raymond James & Associates’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $298M | Buy |
860,050
+257,711
| +43% | +$88.7M | 0.18% | 99 |
|
|
2024
Q2 | $199M | Buy |
602,339
+18,733
| +3% | +$6.46M | 0.13% | 135 |
|
|
2024
Q1 | $212M | Buy |
583,606
+24,708
| +4% | +$8.13M | 0.14% | 124 |
|
|
2023
Q4 | $167M | Sell |
558,898
-6,242
| -1% | -$1.82M | 0.13% | 146 |
|
|
2023
Q3 | $162M | Buy |
565,140
+126,604
| +29% | +$36.1M | 0.14% | 138 |
|
|
2023
Q2 | $123M | Buy |
438,536
+70,775
| +19% | +$18.4M | 0.1% | 181 |
|
|
2023
Q1 | $94M | Sell |
367,761
-66,930
| -15% | -$19.5M | 0.08% | 222 |
|
|
2022
Q4 | $144M | Buy |
434,691
+14,418
| +3% | +$4.56M | 0.13% | 147 |
|
|
2022
Q3 | $117M | Sell |
420,273
-23,992
| -5% | -$6.75M | 0.12% | 161 |
|
|
2022
Q2 | $117M | Buy |
444,265
+51,075
| +13% | +$13.2M | 0.11% | 168 |
|
|
2022
Q1 | $94.2M | Buy |
393,190
+33,117
| +9% | +$7.75M | 0.08% | 218 |
|
|
2021
Q4 | $82.7M | Buy |
360,073
+24,924
| +7% | +$5.3M | 0.07% | 252 |
|
|
2021
Q3 | $67.1M | Buy |
335,149
+67,255
| +25% | +$14.6M | 0.06% | 273 |
|
|
2021
Q2 | $63.5M | Buy |
267,894
+31,238
| +13% | +$7.8M | 0.06% | 283 |
|
|
2021
Q1 | $57.2M | Sell |
236,656
-24,786
| -9% | -$5.52M | 0.06% | 281 |
|
|
2020
Q4 | $54.4M | Buy |
261,442
+26,807
| +11% | +$5.26M | 0.06% | 270 |
|
|
2020
Q3 | $39.8M | Buy |
234,635
+6,347
| +3% | +$1.12M | 0.05% | 309 |
|
|
2020
Q2 | $42.8M | Buy |
228,288
+8,836
| +4% | +$1.68M | 0.06% | 277 |
|
|
2020
Q1 | $38.9M | Sell |
219,452
-520
| -0.2% | -$101K | 0.06% | 255 |
|
|
2019
Q4 | $45M | Sell |
219,972
-17,491
| -7% | -$3.21M | 0.06% | 295 |
|
|
2019
Q3 | $36M | Sell |
237,463
-3,177
| -1% | -$517K | 0.05% | 338 |
|
|
2019
Q2 | $37.9M | Buy |
240,640
+4,584
| +2% | +$718K | 0.05% | 325 |
|
|
2019
Q1 | $38M | Sell |
236,056
-29,654
| -11% | -$5.42M | 0.06% | 318 |
|
|
2018
Q4 | $50.5M | Buy |
265,710
+133,472
| +101% | +$27.8M | 0.09% | 213 |
|
|
2018
Q3 | $27.5M | Sell |
132,238
-1,641
| -1% | -$304K | 0.04% | 413 |
|
|
2018
Q2 | $22.8M | Buy |
133,879
+2,916
| +2% | +$505K | 0.04% | 453 |
|
|
2018
Q1 | $22M | Sell |
130,963
-2,230
| -2% | -$433K | 0.04% | 434 |
|
|
2017
Q4 | $27.1M | Sell |
133,193
-5,367
| -4% | -$1.07M | 0.05% | 366 |
|
|
2017
Q3 | $25.9M | Buy |
138,560
+12,910
| +10% | +$2.3M | 0.05% | 356 |
|
|
2017
Q2 | $21M | Buy |
125,650
+26,528
| +27% | +$4.26M | 0.05% | 406 |
|
|
2017
Q1 | $14.5M | Buy |
99,122
+4,374
| +5% | +$645K | 0.03% | 518 |
|
|
2016
Q4 | $12.6M | Sell |
94,748
-1,469
| -2% | -$192K | 0.03% | 534 |
|
|
2016
Q3 | $12.5M | Sell |
96,217
-4,828
| -5% | -$630K | 0.03% | 508 |
|
|
2016
Q2 | $12.9M | Buy |
101,045
+14,048
| +16% | +$1.85M | 0.04% | 450 |
|
|
2016
Q1 | $11.9M | Sell |
86,997
-1,716
| -2% | -$236K | 0.04% | 460 |
|
|
2015
Q4 | $13M | Buy |
88,713
+18,416
| +26% | +$2.53M | 0.05% | 428 |
|
|
2015
Q3 | $9.49M | Buy |
70,297
+4,418
| +7% | +$641K | 0.04% | 499 |
|
|
2015
Q2 | $10.7M | Sell |
65,879
-1,989
| -3% | -$275K | 0.04% | 493 |
|
|
2015
Q1 | $8.79M | Buy |
67,868
+1,990
| +3% | +$231K | 0.04% | 500 |
|
|
2014
Q4 | $6.78M | Buy |
65,878
+30,137
| +84% | +$2.97M | 0.03% | 546 |
|
|
2014
Q3 | $3.24M | Sell |
35,741
-33,368
| -48% | -$3.12M | 0.02% | 837 |
|
|
2014
Q2 | $6.36M | Sell |
69,109
-13,300
| -16% | -$1.14M | 0.04% | 525 |
|
|
2014
Q1 | $6.9M | Sell |
82,409
-48,433
| -37% | -$3.99M | 0.05% | 455 |
|
|
2013
Q4 | $11.4M | Sell |
130,842
-286
| -0.2% | -$23.4K | 0.09% | 262 |
|
|
2013
Q3 | $10.1M | Buy |
131,128
+1,280
| +1% | +$99.9K | 0.09% | 259 |
|
|
2013
Q2 | $9.41M | Buy |
+129,848
| New | +$8.75M | 0.09% | 251 |
|
Other funds holding CI
Raymond James & Associates's CI Position: Q3 2024 in Review
Raymond James & Associates increased its Cigna (CI) stake by 43% in Q3 2024, buying an estimated $88.7M and bringing the position to 860,050 shares worth $298M. The position accounts for 0.18% of the portfolio, ranked #99.
Raymond James & Associates first reported a position in CI in Q2 2013 and has held it in 46 quarters since. 1,703 funds tracked by Wall St. Rank hold CI as of Q3 2024.
- Raymond James & Associates held 860,050 shares of Cigna worth $298M as of Q3 2024.
- Raymond James & Associates bought 257,711 Cigna shares in Q3 2024, an estimated $88.7M.
- Cigna made up 0.18% of Raymond James & Associates's portfolio in Q3 2024, its #99 holding.
- Raymond James & Associates first reported a position in Cigna in Q2 2013 and has held it in 46 quarters since.
- 1,703 funds tracked by Wall St. Rank held Cigna as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.